These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7894203)

  • 21. Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester.
    Ikuta S; Edamatsu H; Li M; Hu L; Kataoka T
    Cancer Res; 2008 Jan; 68(1):64-72. PubMed ID: 18172297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parallel changes in amino acid transport and protein kinase C localization in LLC-PK1 cells treated with TPA or diradylglycerols.
    Dawson WD; Cook JS
    J Cell Physiol; 1987 Jul; 132(1):104-10. PubMed ID: 3597547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic alterations in tumors that developed from threshold subcutaneous inocula. I. Reduced binding of natural antibodies and sensitivity to hypotonic lysis.
    Brown GW; Lesiuk TP; Chow DA
    J Immunol; 1986 Apr; 136(8):3116-23. PubMed ID: 3958491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of the cytotoxic response of mouse lymphocytes to syngeneic tumor cells by tumor-promoting phorbol ester.
    Fredrickson GG; Bennett M
    Cancer Res; 1982 Sep; 42(9):3601-6. PubMed ID: 7105034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 12-O-tetradecanoylphorbol-13-acetate on the morphology and growth of C3H/10T1/2 mouse embryo cells.
    Boreiko C; Mondal S; Narayan KS; Heidelberger C
    Cancer Res; 1980 Dec; 40(12):4709-16. PubMed ID: 7438102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase C expression links natural antibody binding with surveillance of activated and preneoplastic cells.
    Wang H; Chow DA
    Scand J Immunol; 1999 Apr; 49(4):381-90. PubMed ID: 10219763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural antibody recognition of v-H-ras-induced 10T1/2 transformation.
    Tough DF; Chow DA
    Nat Immun Cell Growth Regul; 1991; 10(2):83-93. PubMed ID: 1652685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies.
    Chow DA
    J Natl Cancer Inst; 1984 Feb; 72(2):339-46. PubMed ID: 6582320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for discrete diacylglycerol and phorbol ester activator sites on protein kinase C. Differences in effects of 1-alkanol inhibition, activation by phosphatidylethanolamine and calcium chelation.
    Slater SJ; Kelly MB; Taddeo FJ; Rubin E; Stubbs CD
    J Biol Chem; 1994 Jun; 269(25):17160-5. PubMed ID: 8006023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of phorbol esters on alloimmune cytolysis.
    Munger WE; Lindquist RR
    Cancer Res; 1982 Dec; 42(12):5023-9. PubMed ID: 6814749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variant generation and selection: an in vitro model of tumor progression.
    Chow DA
    Int J Cancer; 1984 Apr; 33(4):541-5. PubMed ID: 6706435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of concanavalin A capping in phorbol ester-activated lymphocytes by calmodulin inhibitors and certain amino acid esters.
    Kwong CH; Mueller GC
    Cancer Res; 1982 Jun; 42(6):2115-20. PubMed ID: 7200397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of chemotaxis in mouse peritoneal macrophages by activators of protein kinase C.
    Laskin DL; Gardner CR; Laskin JD
    J Leukoc Biol; 1987 Jun; 41(6):474-80. PubMed ID: 3036983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diacylglycerol modulation of insulin receptor from cultured human mononuclear cells. Effects on binding and internalization.
    Grunberger G; Iacopetta B; Carpentier JL; Gorden P
    Diabetes; 1986 Dec; 35(12):1364-70. PubMed ID: 3533683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of [3H]12-O-tetradecanoylphorbol-13-acetate to intact human peripheral blood lymphocytes.
    Estensen RD; DeHoogh DK; Cole CF
    Cancer Res; 1980 Apr; 40(4):1119-24. PubMed ID: 7357543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responses of amphibian embryos and blastomeres to a tumor-promoting phorbol ester.
    Ellinger MS
    Cancer Res; 1982 Jul; 42(7):2804-12. PubMed ID: 7083170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation of TPA-induced down-regulation of T cell antigens from protein kinase C activation.
    Jung LK; Bjorndahl JM; Fu SM
    Cell Immunol; 1988 Dec; 117(2):352-9. PubMed ID: 3264213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological demonstration of protein kinase C mu in murine tissues and various cell lines. Differential recognition of phosphorylated forms and lack of down-regulation upon 12-O-tetradecanoylphorphol-13-acetate treatment of cells.
    Rennecke J; Johannes FJ; Richter KH; Kittstein W; Marks F; Gschwendt M
    Eur J Biochem; 1996 Dec; 242(2):428-32. PubMed ID: 8973662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of tetradecanoylphorbol acetate and diacylglycerol on erythropoietin production in human renal carcinoma cell cultures.
    Hagiwara M; Nagakura K; Ueno M; Fisher JW
    Exp Cell Res; 1987 Nov; 173(1):129-36. PubMed ID: 3678377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.